Psychological and Mental Health of Institutionalized People Over 60 Years of Age With Alzheimer's: Effects of a Digital and Interactive Reminiscence Program.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
- 试验地点
- 2
- 主要终点
- The Quality of Life in Alzheimer's Disease (QoL-AD)
研究概览
简要总结
Digital reminiscence therapy (DRT) is an innovative intervention designed to enhance the psychological health of institutionalized seniors with Alzheimer's disease. This approach utilizes digital tools to facilitate the sharing of personal memories and experiences, fostering social interaction and emotional engagement. By combining technology with therapeutic reminiscence techniques, DRT aims to stimulate cognitive function and improve mood, potentially alleviating symptoms of anxiety and depression commonly observed in this population.
Research indicates that reminiscence therapy can lead to improvements in quality of life and overall well-being for individuals with dementia. The interactive nature of digital platforms encourages participation and allows caregivers to customize content based on the individual's preferences and history. As such, DRT not only serves to strengthen the connections between seniors and their pasts but also enhances their current social interactions, promoting a sense of identity and belonging. Overall, DRT represents a promising avenue for addressing the psychological needs of older adults with Alzheimer's in institutional settings, highlighting the potential benefits of integrating technology into therapeutic practices.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •People over 60 years of age.
- •Confirmed diagnosis of mild or moderate Alzheimer's, where the patient still retains a certain degree of autobiographical memory.
- •People institutionalized in a geriatric care center or similar.
- •Level of cognitive impairment that allows understanding and basic interaction with digital tools.
- •Approval and signature of informed consent by the participant or his/her legal representative, demonstrating agreement to participate in the study.
- •Availability or access to devices (tablets or computers) provided by the study program or the care center.
排除标准
- •Diagnosis of other neurological or psychiatric conditions (such as vascular dementia, Parkinson's, or psychotic disorders) that may significantly interfere with the program's results.
- •Patients in advanced stages of Alzheimer's with severe limitations in remembering autobiographical events or interacting with digital devices.
- •Vision, hearing, or fine motor problems that prevent the use of electronic devices in an appropriate manner, without the possibility of adaptation or assistance.
- •Individuals or legal representatives who are unable or unwilling to give informed consent.
- •Behaviors that may put the participant, staff, or other residents at risk when carrying out program activities.
结局指标
主要结局
The Quality of Life in Alzheimer's Disease (QoL-AD)
时间窗: Up to twelve weeks
This Scale is a 13-item tool that measures quality of life specifically in people with Alzheimer's. Each item is scored from 1 to 4, with a higher score indicating a better perception of quality of life. Areas assessed include mood, physical well-being, relationships, and environment. A high total score suggests a positive perception of quality of life, useful for assessing the impact of psychological and therapeutic interventions.
Mini-Mental State Examination (MMSE)
时间窗: Up to twelve weeks
The most widely used cognitive screening test to assess suspected symptoms consistent with cognitive impairment or dementia. Written test with a maximum score of 30. The cut-off point established for the MMSE defines "normal" cognitive function is generally set at 24, lower scores indicate more serious cognitive problems.
Montreal Cognitive Assessment (MoCA)
时间窗: Up to twelve weeks
Instrument that examines the skills of attention, concentration, executive functions, memory, language, visuoconstructive abilities, calculation and orientation and the maximum score is 30.
Trail Making Test (TMT)
时间窗: Up to twelve weeks
It is used to assess executive function. It measures timed motor and visual tasks, and is divided into two tests: Part A (TMTA), which assesses speed and psychomotor attention and requires connecting consecutively numbered circles; and Part B (TMTB), which tests executive function and requires connecting alternating circles of numbers and letters. Longer completion times indicate poor performance.
Isaacs test
时间窗: Up to twelve weeks
Instrument used to assess verbal fluency. Participants have 60 seconds to generate as many words as possible within a given semantic category (animals, colors, fruits, and cities). The maximum score is 40 points (with a maximum of 10 per category). The higher the score, the better the level of verbal fluency.Instrument used to assess verbal fluency. Participants have 60 seconds to generate as many words as possible within a given semantic category (animals, colors, fruits, and cities). The maximum score is 40 points (with a maximum of 10 per category). The higher the score, the better the level of verbal fluency.
Hospital Anxiety and Depression Scale (HADS)
时间窗: Up to twelve weeks
Assesses symptoms of anxiety (HADS-A) and depression (HADS-D) using 14 items (7 for each subscale), each scored from 0 to 3. Scores range from 0 to 21 for anxiety and for depression, where 0-7 is normal, 8-10 indicates possible symptoms, and 11 or higher suggests a clinical disorder. The HADS is ideal for identifying emotional symptoms in patients with mild to moderate cognitive impairment, complementing the MMSE for a comprehensive assessment of mental and emotional status.
次要结局
未报告次要终点
研究者
Agustín Aibar Almazán
Principal investigator
University of Jaén